TABLE 1.
Characteristics of HIV-positive patients meeting or not meeting indicators for retention in care, antiretroviral therapy (ART) use, and virologic suppression in a cohort from Buenos Aires, Argentina, 2011–2014a
| Characteristic | Total (n = 859) |
Total for retentionb (n = 859)
|
Total for ART usec (n = 563)
|
Total for virologic suppressiond (n = 362)
|
||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Not retained 296 (34.5%) |
Retained 563 (65.5%) |
P | ART not used 104 (18.5%) |
ART used 459 (81.5%) |
P | Not suppressed 92 (25.4%) |
Suppressed 270 (74.6%) |
P | ||
| Age (years) | 33 (27–41) | 31.5 (26–39) | 34 (28–42) | < 0.001 | 32 (27–40) | 34 (28–42) | 0.265 | 33 (27–40) | 34.5 (28–43) | 0.171 |
| Gender | 0.171 | 0.325 | 0.543 | |||||||
| Male | 664 (77.3%) | 237 (35.7%) | 427 (64.3%) | 75 (17.6%) | 352 (82.4%) | 68 (24.6%) | 208 (75.4%) | |||
| Female | 195 (22.7%) | 59 (30.3%) | 136 (69.7%) | 29 (21.3%) | 107 (78.7%) | 24 (27.9%) | 62 (72.1%) | |||
| Transmission risk | 0.962 | 0.298 | 0.146 | |||||||
| MSMe | 276 (32.1%) | 89 (32.2%) | 187 (67.8%) | 39 (20.9%) | 148 (79.1%) | 26 (22.4%) | 90 (77.6%) | |||
| Heterosexual | 249 (29.0%) | 78 (31.3%) | 171 (68.7%) | 26 (15.2%) | 145 (84.8%) | 32 (27.4%) | 85 (72.6%) | |||
| Other/Unknown | 64 (7.5%) | 21 (32.8%) | 43 (67.2%) | 6 (14.0%) | 37 (86.0%) | 11 (40.7%) | 16 (59.3%) | |||
| Missing | 270 (31.4%) | |||||||||
| Residence | 0.498 | 0.013 | 0.626 | |||||||
| Buenos Aires city | 439 (51.1%) | 144 (32.8%) | 295 (67.2%) | 67 (22.7%) | 228 (77.3%) | 47 (26.4%) | 131 (73.6%) | |||
| Other | 394 (45.9%) | 138 (35.0%) | 256 (65.0%) | 37 (14.5%) | 219 (85.5%) | 42 (24%) | 133 (76%) | |||
| Missing | 26 (3%) | |||||||||
| CD4 count (cells/μL) | 358 (134–559) | 377 (187–619) | 343 (121–533) | 0.053 | 648 (510–819) | 360 (171–501) | < 0.001 | 393 (138–593) | 342 (173–488) | 0.153 |
| Missing | 197 (22.9%) | |||||||||
| HIV-1 viral load (log10), copies/μL | 1.38 (3.77–5.00) | 4.43 (3.84–5.12) | 4.36 (3.73–4.94) | 0.325 | 3.6 (3.1–4.2) | 4.5 (3.9–5.1) | < 0.001 | 4.4 (3.9–4.9) | 4.5 (3.9–5.1) | 0.574 |
| Missing | 437 (50.1%) | |||||||||
Data are n (%) or median (interquartile range). Chi-square test of proportions used for categorical variables, and the Wilcoxon rank-sum test of medians used for continuous variables.
Retention indicator: individuals with at least one visit (clinic or laboratory (CD4 or viral load (VL)) or pharmacy pickup) during 2014.
ART use indicator: prescription of ART for at least 90 days or at least three notations of ART pickup from the pharmacy in 2014 among those retained.
Virologic suppression indicator: Viral load (VL)< 200 copies/ml at last measurement in 2014 among those with at least one VL performed in 2014.
MSM = men who have sex with men.